Literature DB >> 3701304

Serum HBsAg, HBeAg, anti-HBe, and hepatitis B viral DNA in asymptomatic carriers in Taiwan.

D S Chen, M Y Lai, S C Lee, P M Yang, J C Sheu, J L Sung.   

Abstract

Plasma samples from 89 asymptomatic hepatitis B surface antigen (HBsAg) positive volunteer blood donors were titrated for HBsAg by radioimmunoassay using the parallel line method. HBsAg titers ranged widely from 0.01 to 325 micrograms/ml. The titers correlated well with hepatitis B viral DNA (HBV DNA) and hepatitis B e antigen (HBeAg) in the serum. The HBsAg titers in 55 HBV DNA positive carriers were 90.7 +/- 61.7 micrograms/ml (Mean +/- SD) vs. 6.3 +/- 12.2 micrograms/ml in the 34 carriers without HBV DNA in the serum. The titers were 93.9 +/- 59.1 micrograms/ml in 56 carriers with HBeAg, 6.4 +/- 10.1 micrograms/ml in 24 anti-HBe-positive carriers, and 4.9 +/- 4.6 micrograms/ml in 9 HBeAg/anti-HBe-negative carriers. 50 (89.3%) of the 56 HBeAg-positive carriers had HBV DNA, in contrast to four (16.7%) of 24 anti-HBe-positive carriers. The study indicated that high-titered HBsAg carriers were much more likely to be infectious, and confirmed that HBeAg is a practical marker of infectivity. Absence of HBeAg, however, did not exclude infectivity in asymptomatic HBsAg carriers, inasmuch as one-sixth of the carriers had HBV DNA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3701304     DOI: 10.1002/jmv.1890190113

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.

Authors:  S L Tsai; P J Chen; M Y Lai; P M Yang; J L Sung; J H Huang; L H Hwang; T H Chang; D S Chen
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

2.  HBV-DNA, HBeAg/anti-HBe serological status in hepatitis B chronic individuals from central Italy.

Authors:  M Rapicetta; V di Nardo; C Rozera; G Marinucci; D Francisci; B Sarrecchia; C Ricci; F Albertoni
Journal:  Epidemiol Infect       Date:  1990-06       Impact factor: 2.451

3.  Prevalence study of different hepatitis markers among pregnant Albanian refugees in Greece.

Authors:  A Malamitsi-Puchner; S Papacharitonos; D Sotos; L Tzala; M Psichogiou; A Hatzakis; A Evangelopoulou; S Michalas
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

4.  Detection of hepatitis B virus DNA in chronic carriers by the polymerase chain reaction.

Authors:  C Malavé Lara; M T Gorriño; C Campelo; P Lardelli; E Suñen; R Cisterna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

5.  The prevalence of serological markers, hepatitis B virus DNA and elevated serum amino transferase values in institutionalized mentally handicapped males and females: an epidemiological study of HBV infection in residents with Down's syndrome or other forms of mental deficiency.

Authors:  T J van Ditzhuijsen; F M Kleijnen; P J Rijntjes; A M van Loon; S H Yap
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

6.  Different interventional criteria for chronic hepatitis B pregnant women with HBeAg(+) or HBeAg(-): Epidemiological data from Shaanxi, China.

Authors:  Tianyan Chen; Jing Wang; Hongtao Qiu; Qiang Yu; Taotao Yan; Caijing Qi; Furong Cao; Zhen Tian; Dandan Guo; Naijuan Yao; Yuan Yang; Yingli He; Yingren Zhao; Jinfeng Liu
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.